Diagnostics Pipeline: 2024 Trends in FDA Approvals
In vitro diagnostic products approved by the U.S. Food and Drug Administration in 2024 show a continued move toward rapid and point-of-care tests
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
In vitro diagnostic products approved by the U.S. Food and Drug Administration in 2024 show a continued move toward rapid and point-of-care tests
From - Diagnostic Testing & Emerging Technologies
Astronauts will soon conduct DNA sequencing in space. National Aeronautics and Space Administration's (NASA's) Biomolecule Sequencer investigation will…
From - Diagnostic Testing & Emerging Technologies
With the movement to legalize marijuana use for medical and/or recreational purposes gaining traction, states are calling for…
From - Diagnostic Testing & Emerging Technologies
Luminex (Austin, Texas) announced this week it will acquire molecular microbiology firm Nanosphere (Northbrook, Ill.) in a cash deal valued at…
From - Diagnostic Testing & Emerging Technologies
Health care experts predict growth and maturation happening in the field of personalized medicine in the next two…
From - Diagnostic Testing & Emerging Technologies
From 2010 to 2015 the Global Measles and Rubella Laboratory Network (GMRLN) substantially increased its capacity to provide real-time disease surveillance and…